SMOBYA OÜ
SMOBYA OÜ is a OÜ based in Tallinn, registry code 16509852, status: active. Main activity: Research and experimental development on biotechnology. According to EMTA, turnover for Q3 2026 was €0 with employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2025 0 €above 5% of companiesindustry median 0 € · companies in the industry: 1 073
Taxes and turnover
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | 3 700 | — | — | — |
| Q1 2026 | 4 700 | — | — | — |
| Q4 2025 | 13 | 3 | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | 23 100 | — | — | — |
| Q1 2025 | 177 | — | — | — |
| Q4 2024 | — | — | — | — |
| Q3 2024 | 112 | — | — | — |
| Q2 2024 | — | — | — | — |
| Q1 2024 | 5 692 | — | — | — |
| Q4 2023 | 1 315 | — | — | — |
| Q3 2023 | 10 757 | — | — | — |
| Q2 2023 | 214 | 1 835 | 1 835 | — |
| Q1 2023 | 10 004 | 132 | 131 | — |
| Q4 2022 | 45 | 1 483 | 1 483 | — |
| Q3 2022 | 120 | 1 100 | 1 100 | — |
Financials by year
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 0 | -23 269 | 52 913 | 17 081 | -15 524 | 4 |
| 2024 | 0 | -4 379 | 96 700 | 40 379 | 7 745 | 4 |
| 2023 | 0 | 37 275 | 58 335 | 48 492 | 12 124 | 5 |
| 2022 | 825 | -27 651 | 13 576 | 3 | -25 151 | 2 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 16 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 14 May 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 27 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 30 May 2022 – 31 Dec 2022 | 3 May 2023 | Company’s own | e-Äriregister |
Board
- Álmos Domonkos KutiBoard member · since 30 May 2022
- Leticia KutiBoard member · since 30 May 2022
- Lídia KutiBoard member · since 30 May 2022
- Réka VargaBoard member · since 30 May 2022
- B2baltics consulting OÜContact person · since 30 May 2022
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Lídia KutiNatural person · 838 €
- Álmos Domonkos KutiNatural person · 788 €
- Réka VargaNatural person · 688 €
- Leticia KutiNatural person · 188 €
Beneficial owners
- Álmos Domonkos KutiDirect ownership · since 30 May 2022
- Lídia KutiDirect ownership · since 30 May 2022
- Réka VargaDirect ownership · since 30 May 2022
Founders and other persons
- Álmos Domonkos KutiFounder · 788 € · 30 May 2022
- Leticia KutiFounder · 188 € · 30 May 2022
- Lídia KutiFounder · 838 € · 30 May 2022
- Réka VargaFounder · 688 € · 30 May 2022
Activities (EMTAK)
- 72111Research and experimental development on biotechnology Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50203960 / 3 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50203960 / 2 18 Oct 2022 |
Amendment entry | In force 18 Oct 2022 |
||
| Ä 50203960 30 May 2022 |
First entry | In force 30 May 2022 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data